WallStreetZenWallStreetZen

NASDAQ: ALIM
Alimera Sciences Inc Stock Ownership - Who owns Alimera Sciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Alimera Sciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Philip AshmanPresident of Intl Operations2024-03-2612,103$3.83
$46.35kSell
Philip AshmanPresident of Intl Operations2024-01-102,938$3.86
$11.34kSell
Caligan Partners LP10% Owner2023-09-14579,000$3.39
$1.96MSell
Caligan Partners LP10% Owner2023-09-14579,000$3.39
$1.96MBuy
Adam MorganDirector2023-08-154,845,392$1.70
$8.24MBuy
Caligan Partners LP10% Owner2023-08-1513,431,616$1.70
$22.83MBuy
Adam MorganDirector2023-08-154,178,725$1.70
$7.10MBuy
Adam MorganDirector2023-08-152,924,762$2.10
$6.14MBuy
Caligan Partners LP10% Owner2023-08-152,924,761$2.10
$6.14MBuy
Adam MorganDirector2023-05-171,401,901$1.70
$2.38MBuy

1 of 1

ALIM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALIM insiders and whales buy or sell their stock.

ALIM Shareholders

What type of owners hold Alimera Sciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Caligan Partners LP32.16%16,835,154$61.11MInsider
Caligan Partners LP32.16%16,835,154$61.11MInstitution
Armistice Capital LLC26.42%13,832,000$50.21MInsider
Adam Morgan25.99%13,608,533$49.40MInsider
Velan Capital Investment Management LP25.99%13,608,533$49.40MInstitution
Palo Alto Healthcare Master Fund LP12.67%6,634,295$24.08MInsider
Venrock Associates Iv L P11.86%6,209,433$22.54MInsider
James E. Flynn11.23%5,878,015$21.34MInsider
Mark J. 1. Brooks9.29%4,863,094$17.65MInsider
Brian H. Dovey8.00%4,189,427$15.21MInsider

1 of 3

ALIM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALIM29.08%70.92%Net BuyingNet Selling
OGI5.56%0.00%
LFCR49.15%50.85%
FTLF0.86%99.14%Net Buying
ZOM8.89%6.87%Net Buying
View Top Pharmaceutical Stocks

Alimera Sciences Stock Ownership FAQ

Who owns Alimera Sciences?

Alimera Sciences (NASDAQ: ALIM) is owned by 92.13% institutional shareholders, 224.68% Alimera Sciences insiders, and 0.00% retail investors. Caligan Partners LP is the largest individual Alimera Sciences shareholder, owning 16.84M shares representing 32.16% of the company. Caligan Partners LP's Alimera Sciences shares are currently valued at $55.72M.

If you're new to stock investing, here's how to buy Alimera Sciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.